MedTrace Logo

GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes

NCT01414556 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2013-04-02

No results posted yet for this study

Summary

Investigation of GIP effects at fasting and hypoglycemia

Conditions

Interventions

OTHER

Glucose-dependent Insulinotropic polypeptide

infusion 4 pmol x kg x min first 15 min, thereafter 2 pmol x kg x min

OTHER

saline

Sponsors & Collaborators

  • Mikkel Christensen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-07-31
Completion
2012-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01414556 on ClinicalTrials.gov